Indaptus Therapeutics (INDP) Shares Outstanding (2020 - 2026)
Indaptus Therapeutics (INDP) reported Shares Outstanding of 64.11 million for Q2 2026, compared with 574,923 a year earlier and up 485.1% from the prior quarter.
Powered by 
Analysis
Indaptus Therapeutics (INDP) Shares Outstanding (2020 - 2026) Analysis & Trends
For FY2025, Indaptus Therapeutics posted Shares Outstanding of 966,124, up 189.2% from FY2024.
- Shares Outstanding has increased for five consecutive years, with a five-year compound annual growth rate of 69.3% (FY2020 to FY2025).
- By year, Shares Outstanding came in at 334,092 in FY2024 (+11.4%), 300,001 in FY2023 (+1.7%), 295,040 in FY2022 (+102.0%) and 146,075 in FY2021 (+110.3%).
- The Q2 2026 figure ranks as the highest quarterly Shares Outstanding in data going back to Q1 2020.
- Across the past five years, year-over-year growth in Shares Outstanding ran from 0.5% in Q1 2024 to 324.7% in Q2 2022.
- Per Business Quant data, the three quarters before Q2 2026 came in at 10.96 million (Q1 2026), 966,124 (Q4 2025) and 997,038 (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Shares Outstanding (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 638.12 Bn | 556.64 Bn | 17.26 Bn | 2.41 Bn |
| 2 | AbbVie | 462.60 Bn | 435.75 Bn | 12.70 Bn | 1.77 Bn |
| 3 | Merck | 358.70 Bn | 313.13 Bn | 12.21 Bn | 2.47 Bn |
| 4 | Novartis Ag | 272.16 Bn | 228.03 Bn | 11.24 Bn | 1.94 Bn |
| 5 | Astrazeneca | 250.36 Bn | 223.92 Bn | 12.86 Bn | 1.55 Bn |
| 6 | Amgen | 227.87 Bn | 183.27 Bn | 7.24 Bn | 540.00 Mn |
| 7 | Gilead Sciences | 184.97 Bn | 159.08 Bn | 6.22 Bn | 1.24 Bn |
| 8 | Pfizer | 162.61 Bn | 109.56 Bn | 10.94 Bn | 5.70 Bn |
| 9 | Vertex Pharmaceuticals | 132.45 Bn | 104.46 Bn | 2.84 Bn | 253.70 Mn |
| 10 | Indaptus Therapeutics | 147.46 Mn | 120.07 Mn | - | 64.11 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 64.11 Mn |
| Mar 31, 2026 | 10.96 Mn |
| Dec 31, 2025 | 966,124.00 |
| Sep 30, 2025 | 997,038.00 |
| Jun 30, 2025 | 574,923.00 |
| Mar 31, 2025 | 503,596.00 |
| Dec 31, 2024 | 334,092.00 |
| Sep 30, 2024 | 339,618.00 |
| Jun 30, 2024 | 305,103.00 |
| Mar 31, 2024 | 301,477.00 |
| Dec 31, 2023 | 300,001.00 |
| Sep 30, 2023 | 300,001.00 |
| Jun 30, 2023 | 300,001.00 |
| Mar 31, 2023 | 300,001.00 |
| Dec 31, 2022 | 295,040.00 |
| Sep 30, 2022 | 294,914.00 |
| Jun 30, 2022 | 294,914.00 |
| Mar 31, 2022 | 294,914.00 |
| Dec 31, 2021 | 146,075.00 |
| Sep 30, 2021 | 149,294.00 |
API Access
Indaptus Therapeutics Shares Outstanding API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=shares-outstanding&ticker=INDP&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "shares-outstanding", "ticker": "INDP", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=shares-outstanding&ticker=INDP&period=max&api_key=YOUR_API_KEY");
const data = await res.json();